➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Potassium chloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for potassium chloride and what is the scope of freedom to operate?

Potassium chloride is the generic ingredient in forty-four branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Glenmark Pharms Ltd, Granules, Lannett Co Inc, Lupin Ltd, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Pharma Res Software, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Nexus Pharms, Icu Medical Inc, Apotex, Genus Lifesciences, Pharm Assoc, Saptalis Pharms, Future Pak, Abbvie, Apothecon, Amta, Ascent Pharms Inc, Aurobindo Pharma Ltd, Centaur Pharms Pvt, Copley Pharm, Mylan, Schering, Sigmapharm Labs Llc, Vitruvias Therap, Yichang Humanwell, and Novartis, and is included in one hundred and sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and forty drug master file entries for potassium chloride. Eighty-seven suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for potassium chloride

US Patents:	0
Tradenames:	44
Applicants:	56
NDAs:	116
Drug Master File Entries:	240
Finished Product Suppliers / Packagers:	87
Raw Ingredient (Bulk) Api Vendors:	260
Patent Applications:	300
Drug Prices:	Drug price trends for potassium chloride
Drug Sales Revenues:	Drug sales revenues for potassium chloride
What excipients (inactive ingredients) are in potassium chloride?	potassium chloride excipients list
DailyMed Link:	potassium chloride at DailyMed

See drug prices for potassium chloride

Drug Sales Revenue Trends for potassium chloride

See drug sales revenues for potassium chloride

Generic filers with tentative approvals for POTASSIUM CHLORIDE

Applicant	Application No.	Strength	Dosage Form
⤷ Try it Free	⤷ Try it Free	20MEQ	Tablet; Oral
⤷ Try it Free	⤷ Try it Free	10MEQ	Tablet, Extended Release; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for potassium chloride

Drug Class	Potassium Salt Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

US Patents and Regulatory Information for potassium chloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Copley Pharm	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	070618-001	Sep 9, 1987		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Upsher Smith Labs	KLOR-CON	potassium chloride	FOR SOLUTION;ORAL	209662-001	Oct 23, 2017	AA	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Novel Labs Inc	POTASSIUM CHLORIDE	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	204828-001	Aug 16, 2016	AB	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Actavis Labs Fl Inc	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	075604-002	Apr 10, 2002	AB1	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Padagis Us	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	205993-001	Nov 5, 2015	AB2	RX	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Baxter Hlthcare	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%	potassium chloride; sodium chloride	INJECTABLE;INJECTION	017648-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for potassium chloride

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Schering	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	019439-002	Jun 13, 1986	⤷ Try it Free	⤷ Try it Free
Nesher Pharms	MICRO-K	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	018238-001	Approved Prior to Jan 1, 1982	⤷ Try it Free	⤷ Try it Free
Kv Pharm	MICRO-K LS	potassium chloride	FOR SUSPENSION, EXTENDED RELEASE;ORAL	019561-003	Aug 26, 1988	⤷ Try it Free	⤷ Try it Free
Apothecon	KLOTRIX	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	017850-001	Approved Prior to Jan 1, 1982	⤷ Try it Free	⤷ Try it Free
Schering	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	019439-001	Jun 13, 1986	⤷ Try it Free	⤷ Try it Free
Nesher Pharms	MICRO-K 10	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	018238-002	May 14, 1984	⤷ Try it Free	⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.